Pilot Study Probes Dapagliflozin Use in Patients Receiving Dialysis

A pilot study investigated the dialyzability and pharmacokinetics of dapagliflozin, an SGLT2 inhibitor, in patients on dialysis for kidney failure.

Related Keywords

Brazil ,New York ,United States ,American ,Andreic Sposito ,Cidade Universit ,Calvin Meaney ,Sciences In Buffalo ,University At Buffalo School Of Pharmacy ,University Of Minnesota ,Clinical Journal ,American Society ,Wendy St Peter ,Buffalo School ,Pharmaceutical Sciences ,